Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

Part of paid clinical trials in Farmington, Connecticut.

Sponsor
UConn Health
Study ID
NCT01630421
Status
Recruiting

Conditions

  • Aplasia Cutis Congenita

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.

Key Dates

Start date
Apr 30, 2009
Status verified
Apr 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
600 participants (estimated)

Arms

  • Arm: affected, unaffected
    Individuals with diagnosed ACC

Primary Outcome Measure

Identification of genetic elements [ Time Frame: at time of identification ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Connecticut Health CenterFarmingtonConnecticut06030
Ernst J Reichenberger, PhD
860-679-2062

Find similar trials in Farmington, CT